Urinalysis Results in Healthy Individuals

June 2, 2020 updated by: Kendall Healthcare Group, Ltd.

The Frequency of Leukocytes and Nitrites in the Urine of Healthy Adults

This is a prospective, observational study assessing the results of urine dipsticks on adult volunteers with no acute symptoms. We seek to determine the frequency of leukocytes or nitrites in this group of individuals.

Study Overview

Status

Completed

Detailed Description

The urinalysis (UA) is one of the most commonly utilized tests in the emergency department (ED). In some busy EDs, a UA is routinely ordered by protocol on patients with abdominal pain, and in elderly patients, a UA is often ordered for a variety of chief complaints including dizziness and altered mental status. When these patients, who often do not specifically have symptoms of a urinary tract infection, have a urinalysis demonstrating pyuria or bacteria, it may be interpreted as an atypical presentation of a UTI. However, it is possible that these patients do not have urinary tract infections, but have baseline pyuria or bacteriuria. One prior study found that 5% of sexually active healthy women 18-40 have asymptomatic bacteriuria [1], and the rate of asymptomatic bacteriuria increases with age, such that it is present in 8-10% of women from 70-80 years of age [2]. Moreover, one prior article stated that 30-50% of residents of long term nursing facilities have positive urine cultures at any given time [3].

The above statistics come from the results of urine cultures. In the ED, the decision to treat or not treat a patient for a UTI is not made based upon culture results, but upon a urinalysis (microscopic or dipstick). Only one prior study has looked at the frequency of abnormal urinalyses in healthy individuals, and it found that over a third of asymptomatic women had at least 1+ leukocytes in their urine [4]. This is evidence that a substantial number of people who do not have symptomatic UTIs have UAs that could be interpreted as UTIs. If these results could be replicated and expanded to include a wider group of individuals (males, elderly patients, various races, etc.), it would provide valuable information about how we can better interpret and utilize the results of a UA.

Thus, the investigators propose a prospective study to assess the frequency of abnormal UAs in a wide variety of individuals without acute symptoms.

Urine samples will be obtained from adults with no acute symptoms, and performed urine dipsticks to assess the frequency of leukocytes or nitrites in the urine. Patients will be divided into groups to determine if there are certain factors (gender, age, or medical history) that increase the chance of having leukocytes or nitrites in the urine.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33175
        • Kendall Regional Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects are all healthy volunteers, who are primarily family, friends, or acquaintances of study investigators.

Description

Inclusion Criteria:

  • Age > 18 years
  • Able to spontaneously provide a urine sample

Exclusion Criteria:

  • Any acute symptoms (including but not limited to vaginal bleeding, vaginal discharge, abdominal pain, back pain, dysuria, hematuria, and fever)
  • Pregnancy
  • Prisoner status
  • Antibiotics within 72 hours
  • Urologic procedure within a week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Asymptomatic Male Volunteers
These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male.
A sample of urine will be tested using a Mission Urinalysis Reagent Strip.
Asymptomatic Female Volunteers
These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female.
A sample of urine will be tested using a Mission Urinalysis Reagent Strip.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
False Positive Urine
Time Frame: The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.
A urine sample with at least 1+ leukocytes or positive nitrites on urine dipstick test will be considered a "false positive urine".
The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidental Hematuria
Time Frame: The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.
A urine sample with any blood on urine dipstick test will be considered to have "incidental hematuria"
The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tony Zitek, MD, Nova Southeastern University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2019

Primary Completion (Actual)

December 30, 2019

Study Completion (Actual)

January 2, 2020

Study Registration Dates

First Submitted

August 12, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (Actual)

August 14, 2019

Study Record Updates

Last Update Posted (Actual)

June 18, 2020

Last Update Submitted That Met QC Criteria

June 2, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-356 Non-NSU Health

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asymptomatic Bacteriuria

Clinical Trials on Urine dipstick test

3
Subscribe